A positive clinical trial is usually a signal for a biotech startup to press the accelerator on its spending, but Kronos Bio is taking a different tack. The Californian biotech is axing 19% of its ...
We rarely invite the same band back to the Tiny Desk. But the beloved Kronos Quartet, which first played our offices 12 years ago, isn't the same band. Three of the four members are brand new: Cellist ...
From how to French brain or play the guitar to how to unclog a sing or perform CPR, you can learn all kinds of useful skills on YouTube. We at Mental Floss are always eager to learn new things and ...
UK-based Ignota Labs has acquired all of the clinical-stage assets in Kronos Bio's pipeline, after the US company ceased operations earlier this year. Ignota specialises in turning around promising ...
Today (July 16) marks the 80th anniversary of the Trinity test, during which a team of U.S. scientists led by J. Robert Oppenheimer detonated the world’s first atomic bomb in the deserts of New Mexico ...
Get exclusive reporting, live Q&As and ad-free reading. It’s a question Asa Chandler hasn’t stopped asking since he heard his old friend Tony Kronos was missing. The 40-year-old was last seen at his ...
Concentra Biosciences inked a definitive deal to acquire Kronos Bio’s common stock for 57 cents per share. (cagkansayin/GettyImages) With the walls quickly closing ...
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small molecule therapeutics to address cancers and ...
NAMM 2025: Korg has revived its beloved Kronos workstation, unveiling an updated model that promises to be faster and more flexible then previous incarnations, as well as being packed with fresh ...
Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...
Kronos Bio, a San Mateo biotech company, is losing millions of dollars a month and recently had to discontinue its sole clinical-stage compound because of adverse side effects. Now, the company is ...
The clock is ticking for Kronos Bio after the biotech discontinued its last remaining clinical-stage asset over neurological adverse events. The San Mateo, California-based biotech said it had made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results